Oxford Asset Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-19,155
| Closed | -$170K | – | 1941 |
|
|
2019
Q3 | $170K | Sell |
19,155
-7,454
| -28% | -$66.2K | ﹤0.01% | 1588 |
|
|
2019
Q2 | $380K | Buy |
26,609
+12,823
| +93% | +$183K | 0.01% | 1374 |
|
|
2019
Q1 | $453K | Sell |
13,786
-10,583
| -43% | -$348K | 0.01% | 1257 |
|
|
2018
Q4 | $1.45M | Buy |
24,369
+2,503
| +11% | +$149K | 0.04% | 662 |
|
|
2018
Q3 | $3.07M | Buy |
21,866
+9,190
| +72% | +$1.29M | 0.06% | 423 |
|
|
2018
Q2 | $1.48M | Sell |
12,676
-2,657
| -17% | -$311K | 0.03% | 838 |
|
|
2018
Q1 | $1.37M | Buy |
15,333
+3,159
| +26% | +$282K | 0.03% | 777 |
|
|
2017
Q4 | $679K | Sell |
12,174
-2,085
| -15% | -$116K | 0.01% | 1088 |
|
|
2017
Q3 | $585K | Buy |
14,259
+5,616
| +65% | +$230K | 0.01% | 1143 |
|
|
2017
Q2 | $364K | Buy |
+8,643
| New | +$364K | 0.01% | 1199 |
|
|
2016
Q2 | – | Sell |
-2,049
| Closed | -$164K | – | 846 |
|
|
2016
Q1 | $164K | Sell |
2,049
-17,648
| -90% | -$1.41M | ﹤0.01% | 726 |
|
|
2015
Q4 | $1.5M | Buy |
+19,697
| New | +$1.5M | 0.04% | 450 |
|